Four biotechs completed IPOs in 3Q12, raising $183 million. In 3Q11, three companies raised $213.6 million. Thirteen biotechs have raised $776.4 million via IPOs so far in 2012, compared with 14 that raised $727.7 million in the first nine months of 2011. The 2012 IPOs are up a median of 10%, led by